Malaria vaccine hailed as potential breakthrough
Early trials show Oxford developers may have finally found an effective jab against the disease. …
In a pre-print study with The Lancet, the research team – from Oxford, Nanoro in Burkina Faso and the US – reported the trial results of R21/Matrix-M, after testing a low and high dose of the vaccine in children, between May and August, before peak malaria season.
About The Author
